Vident Advisory, LLC Acadia Pharmaceuticals Inc Call Options Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
286Shares Held
160MCall Options Held
723KPut Options Held
257K-
Baker Bros. Advisors LP New York, NY42.9MShares$757 Million9.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$242 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$242 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$213 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$102 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.86B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...